LMR Partners’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12M Buy
+482,750
New +$1.46M ﹤0.01% 1058
2025
Q1
– Sell
-77,300
Closed -$121K – 1589
2024
Q4
$121K Sell
77,300
-2,700
-3% -$7.79K ﹤0.01% 983
2024
Q3
$294K Buy
+80,000
New +$280K ﹤0.01% 916

Other funds holding PYXS

LMR Partners's PYXS Position: Q3 2026 in Review

LMR Partners opened a new position in Pyxis Oncology (PYXS) in Q3 2026: 482,750 shares worth $1.12M. The stake represents ﹤0.01% of the portfolio and ranks #1058 among its holdings. This is a return to the name: LMR Partners previously reported a position in PYXS as recently as Q4 2024.

LMR Partners first reported a position in PYXS in Q3 2024 and has held it in 3 quarters since. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • LMR Partners held 482,750 shares of Pyxis Oncology worth $1.12M as of Q3 2026.
  • Pyxis Oncology was a new LMR Partners position in Q3 2026.
  • Pyxis Oncology made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1058 holding.
  • LMR Partners first reported a position in Pyxis Oncology in Q3 2024 and has held it in 3 quarters since.
  • 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.